GPCRs, radiopharma and the rise of functional peptide screening

Leave a Comment / By /

Renewed pharma interest in GPCR biology and radioligand therapies is drawing attention to functional peptide screening platforms.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top